Archives
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Ionomycin Calcium Salt: Decoding Calcium Signaling in Can...
2025-09-30
Explore the multifaceted role of ionomycin calcium salt, a potent calcium ionophore, in modulating intracellular Ca2+ signaling, apoptosis, and tumor suppression. This article uniquely bridges molecular mechanisms with translational cancer research, offering new insights for investigators.
-
CB-5083: Advanced Disruption of Protein Degradation Pathw...
2025-09-29
Discover how CB-5083, a selective p97 inhibitor, redefines cancer research by targeting protein degradation and unfolded protein response. This article uniquely explores CB-5083’s mechanistic depth, translational applications, and emerging insights in ER membrane regulation.
-
Biotin-tyramide: Precision Signal Amplification in Immune...
2025-09-28
Explore how Biotin-tyramide empowers enzyme-mediated signal amplification for dissecting immune signaling and drug discovery. This article uniquely connects tyramide-based amplification to chemoproteomic advances and autoimmune disease research.
-
Brefeldin A: Mechanisms and Advanced Oncology Applications
2025-09-27
Explore how Brefeldin A (BFA), a potent ATPase and vesicle transport inhibitor, is revolutionizing research in protein trafficking, ER stress, and cancer cell apoptosis. Discover its unique mechanistic insights and advanced biomedical applications.
-
Torin 1: Advancing mTOR Inhibition in Lipid Metabolism an...
2025-09-26
Discover how Torin 1, a potent mTOR inhibitor, is transforming mTOR signaling pathway research by enabling unprecedented insights into lipid metabolism, cell proliferation inhibition, and therapeutic modeling. This article explores unique experimental strategies and mechanistic depth not covered elsewhere.
-
Phosbind Acrylamide: Mechanistic Insights for Antibody-Fr...
2025-09-25
Discover how Phosbind Acrylamide, a leading phosphate-binding reagent, enables in-depth, antibody-free protein phosphorylation analysis through its unique mechanism of action. This article explores advanced mechanistic principles, key applications in signaling research, and new insights into phosphorylation-dependent mobility shifts.
-
Genotyping Kit for Target Alleles: Mechanistic Insights &...
2025-09-24
Explore the Genotyping Kit for target alleles of insects, tissues, fishes and cells—a rapid genomic DNA preparation kit enabling efficient PCR amplification of genomic DNA. This article uniquely reveals the mechanistic underpinnings, contamination prevention strategies, and advanced research applications, setting it apart from existing resources.
-
Nonivamide: TRPV1 Agonism and Mitochondrial Apoptosis in ...
2025-09-23
Explore the multifaceted role of Nonivamide, a capsaicin analog and TRPV1 receptor agonist, as an anti-proliferative agent for cancer research. This article analyzes its distinct mitochondrial apoptosis mechanisms and in vivo tumor inhibition, with a focus on translational experimental strategies.
-
On the other hand there was no
2025-03-03
On the other hand, there was no difference in effectiveness performing ALK by FISH with regard to the sample site. When it was extracted from the primary tumor, we obtained 27.4% of not-evaluable specimens. Similar percentages were found for node (26.7%) and tie2 (31.3%) samples (p = 0.903). Disc
-
COPD is almost unheard of in individuals less than years
2025-03-03
COPD is almost unheard of in individuals less than 40 years of age (even among heavy smokers), 1 in 10 lifetime never-smokers and 1 in 3 develop COPD by age 75 [26], unquestionably, COPD is an age-related disorder. This notion of accelerated ageing of COPD is supported by animal models, which demons
-
The PAS domains of AHR consist of two
2025-03-03
The PAS domains of AHR consist of two regions, PAS-A and PAS-B, which function as interfaces for dimerization with ARNT and for ligand binding, respectively [14]. Although both the bHLH and the PAS-A domains have been shown to be involved in dimerization with ARNT, a recent report suggests that only
-
Recent studies demonstrated that AHR has an important role i
2025-03-03
Recent studies demonstrated that AHR has an important role in the interplay between cancer metabolism and tumor-specific immunity. Tryptophan catabolism is increasingly recognized as a metabolic pathway that promotes tumorigenesis through its role in immune suppression [75]. The rate-limiting enzyme
-
In the search for more specific inhibitors of uptake Iversen
2025-03-03
In the search for more specific inhibitors of uptake2, Iversen and Salt (1970) speculated that steroids may potentiate the actions of catecholamines on vascular smooth muscle by inhibiting uptake2-mediated catecholamine clearance of the transmitters. They went on to demonstrate that a variety of ste
-
br Therapeutic advantages and clinical implications of caffe
2025-03-03
Therapeutic advantages and clinical implications of caffeine treatment in ROP The demonstration of the role of the adenosine receptor in development of ROP and protection by caffeine suggests two potential therapeutic strategies with high translational potential: a) modification of caffeine treat
-
br Conclusions and clinical relevance Astrogliosis and an in
2025-03-03
Conclusions and clinical relevance Astrogliosis and an increase in ADK is a pathologcial hallmark of epilepsy. The consequence of increased ADK in the epileptic rutin supplement is a decrease in the ambient adenosine tone and A1R activity. As a result, systemic administration of A1R agonists or